Our West network has been featured in a recent article by MLK50 for advancing equity in cancer care. Diversity across our clinical trials is significantly higher than national averages and reflects our commitment to making oncology research more inclusive and representative for all patients.
The article also highlights the impactful work of 3 of our own team members: Dr. Gregory Vidal, Dr. Andrea Curry, and Yoriann Hull. Their leadership is helping reshape clinical research to better serve all patients.